BALAXI PHARMACEUTICALS LIMITED (BALAXI) — share transfer | 9 July 2026
Balaxi Pharmaceuticals announced receipt of a SEBI-mandated certificate for the quarter ended June 30, 2026, confirming compliance with share dematerialization procedures under Regulation 74(5). The filing details the Registrar's role and availability of the certificate on the company website.
About BALAXI PHARMACEUTICALS LIMITED (BALAXI)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when BALAXI files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track BALAXI — Free💡 Ask AI about this filing
📊 More BALAXI filings
- 🟡 Board Meeting — 24 August 2026 BALAXI PHARMACEUTICALS LIMITED held its 83rd Annual General Meeting on 24 August 2026 via video conf...
- 🔴 Annual Report — 10 August 2026 BALAXI PHARMACEUTICALS LIMITED issued a corrigendum correcting the cut-off date for voting eligibili...
- share transfer — 7 August 2026 BALAXI PHARMACEUTICALS LIMITED reported that no transfer requests were approved or rejected in July ...
- 🔴 Financial Results — 6 August 2026 Balaxi Pharmaceuticals reported consolidated revenue of ₹80.68 crore for Q1 FY27, a 14% YoY increase...
- 🔴 Annual Report — 31 July 2026 Balaxi Pharmaceuticals Limited filed its Business Responsibility and Sustainability Report for FY 20...
🔥 Also filed on 9 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when BALAXI files new disclosures
Track BALAXI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BALAXI — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd